GlaxoSmithKline PLC
Summary Details
| Previous Name: | (27 Dec 00) Glaxo Wellcome PLC |
|---|---|
| ACTIVITIES: | GlaxoSmithKline is dedicated to the discovery, development manufacture and marketing of pharmaceuticals, vacines, over the counter medicines and health related consumer products. It manufactures its products in over 70 countries and sells them in most countries throughout the world |
| STATUS: | Full; Lon option; ADR. |
| INDEX: | FTSE 100, techMARK |
| SECTOR: | Pharmaceuticals & Biotechnology |
| NO.EMP: | 99,503 (99,820). |
| REM: | £5246m (£4694m). |
| GEARING: | gross 200% (158%), net of cash 70.0% (127%). |
| ROCE: | 49.3% (49.0%). |
| 1ST QTR: | (27 Apr 06) 3 mths to 31 Mar 06. T/O £5,813m (£5,036m). Pre tax profit £2,170m (£1,711m). EPS 26.3p (21.0p). 1st qtr div 10.0p (10.0p) |
| NOTES: | Figures for 31st Dec 2005 are in accordance with IFRS |
2nd May 2006